Submit Release
News Search

There were 1,677 press releases posted in the last 24 hours and 401,843 in the last 365 days.

Third Generation Sequencing Market Set to Witness Unprecedented Growth of USD 28.73 Billion by 2030, Size, Share, Trends, Growth Opportunities and Competitive Outlook

Data Bridge Market Research analyses that the third generation sequencing market which was USD 9.01 billion in 2022, is expected to reach USD 28.73 billion by 2030, at a CAGR of 15.60% during the forecast period 2023 to 2030

LONDON, June 06, 2023 (GLOBE NEWSWIRE) -- The newest report from Data Bridge Market Research, "Third Generation Sequencing Market" examines growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and the competitive environment in detail. In order to thrive in the rapidly evolving marketplace, businesses today require innovative and exceptional solutions. The Third Generation Sequencing market research report serves as an outstanding resource, offering up-to-date technical and financial insights into the industry until 2030. Clients gain an unparalleled understanding of the best market opportunities within their respective sectors through this comprehensive report. Market segmentation is extensively covered, considering multiple aspects that can greatly assist businesses.

The global Third Generation Sequencing market report provides in-depth market data and forecasts by analyzing key business trends and identifying potential growth pathways across the entire value chain. This international report is a result of combining industry expertise, practical solutions, talent resources, and the latest technology. It presents a methodical investigation of the current global market scenario, taking into account various market dynamics. By leveraging the market data presented in this report, emerging trends, major drivers, challenges, and opportunities within the Third Generation Sequencing industry can be identified and analyzed. The report incorporates excellent practice models and utilizes robust research methods to unveil the best opportunities for thriving in the market. It explores markets at the local, regional, and global levels, ensuring a comprehensive and insightful perspective.

Data Bridge Market Research analyses that the third-generation sequencing market which was USD 9.01 billion in 2022, is expected to reach USD 28.73 billion by 2030, at a CAGR of 15.60% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get a Sample PDF of the Third Generation Sequencing Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-third-generation-sequencing-market

The emergence of third-generation sequencing (TGS) technology has revolutionized the field of biology by offering unprecedented resolution in studying genomes, transcriptomes, and metagenomes. These advanced sequencing technologies utilize single-molecule sequencing, providing several key advantages. These include the generation of long reads without the need for amplification, the direct detection of epigenetic modifications on native DNA, and the ability to sequence through previously inaccessible or challenging regions of the genome that short-read platforms struggle to analyze.

In parallel with the increasing digitalization of the world, the third-generation sequencing market has also gained legal recognition. What was once considered a niche practice in technological advancements and biomedical research has now become a vibrant industry with numerous high-tech firms and dedicated scientists. The wide range of applications for third-generation sequencing has contributed to the rapid growth of this market in recent years.

The expansion of the third-generation sequencing market is primarily driven by the growing demand for early disease detection and personalized medicine. As the need for precise and individualized healthcare solutions continues to rise, the use of TGS technology is expected to play a crucial role in meeting these requirements. The remarkable potential of third-generation sequencing in enabling accurate diagnostics and tailored treatments has fueled its market growth and solidified its position in the biomedical landscape.

Opportunities:

  • Technological advances

The market growth in DNA sequencing is propelled by various factors, including significant advancements in sequencing technology, expanded applications in clinical diagnosis and drug discovery, and increased investments in research and development. DNA sequencing has proven instrumental in numerous areas such as diagnostics, personalized medicine, biomarker identification, forensics, and reproductive health, among others.

The advent of third-generation sequencing technology has unlocked tremendous potential, particularly in the fields of cancer diagnostics and therapeutics clinical research and development. This cutting-edge technology enables researchers to delve deeper into understanding the genetic aspects of cancer, paving the way for more accurate diagnostics and innovative treatment approaches.

Additionally, next-generation sequencing (NGS) technology has emerged as a high-throughput and cost-effective method for identifying and characterizing clinically relevant genetic variants across multiple genes in a single test. This breakthrough has revolutionized genetic analysis by streamlining the process and making it more accessible and efficient.

As a result of these advancements, the market for DNA sequencing continues to experience robust growth, driven by the increasing demand for precise diagnostics, personalized healthcare solutions, and enhanced genetic insights. The convergence of technology, clinical applications, and research investments has propelled the field of DNA sequencing to new heights, with far-reaching implications for various industries and scientific endeavors.

The most prominent players in the Third Generation Sequencing market include.

  • Thermo Fisher Scientific, Inc. (U.S.)
  • Illumina, Inc. (U.S.)
  • QIAGEN(Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Oxford Nanopore Technologies Ltd. (U.K.)
  • Macrogen, Inc. (South Korea)
  • Perkin Elmer, Inc. (U.S.)
  • Pacific Biosciences of California, Inc. (U.S.)
  • BGI (China)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Myriad Genetics (U.S.)
  • Agilent Technologies, Inc. (U.S.)

Click Here to Download the Complete Research Study in PDF Format @
https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-third-generation-sequencing-market

Core Objective of Third Generation Sequencing Market:

Every firm in the Third Generation Sequencing market has objectives but this market research report focus on the crucial objectives, so you can analysis about competition, future market, new products, and informative data that can raise your sales volume exponentially.

  • Third Generation Sequencing Market Size and growth rate factors.
  • Important changes in the future Third Generation Sequencing Market.
  • Top worldwide competitors of the Market.
  • Scope and product outlook of Third Generation Sequencing Market.
  • Developing regions with potential growth in the future.
  • Tough Challenges and risk faced in the Market.
  • Global Third Generation Sequencing top manufacturers profile and sales statistics.

Key Market Segments Covered in Third-Generation Sequencing Industry Research

Type

  • Single Molecule Real Time (SMRT) DNA Sequencing
  • Nanopore-based Single-Molecule Analysis Technology

Application

  • Methylation Studies
  • Single Nucleotide Polymorphisms (SNP) Detection

Restraints/Challenges:

The growth of the third-generation sequencing market during the forecast period may face challenges due to several factors. The easy availability of substitutes, unfavorable government policies, and the associated risks with sequencing are likely to hinder the market growth. Additionally, the market may be impacted by the economic recession and increasing competition among competitors.

Despite these challenges, this report on the third-generation sequencing market provides comprehensive insights into various aspects. It covers recent developments, trade regulations, import-export analysis, production analysis, optimization of the value chain, market share, the impact of domestic and localized market players, opportunities in emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches, product approvals, product launches, geographic expansions, and technological innovations.

For more detailed information about the third-generation sequencing market, interested parties are encouraged to contact Data Bridge Market Research for an Analyst Brief. Their expert team will provide valuable assistance in making informed market decisions to achieve market growth.

Key Industry Drivers:

  • Rising applications of Third-generation sequencing

Third-generation sequencing technologies can produce much longer reads than second-generation sequencing technologies. These advantages have significant implications for genomic science as well as general biology research. These technologies are actively being developed, and reductions in high error rates are expected. These all are the certain factors that help the market to grow.

Explore Further Details about This Research Report @ https://www.databridgemarketresearch.com/reports/global-third-generation-sequencing-market

Third-Generation Sequencing Market Regional Analysis/Insights:

The countries covered in the third-generation sequencing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the third-generation sequencing market because of the high prevalence of breast cancer patients.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the focus of various established market players to expand their presence in this particular region.

The report encompasses a wide range of insightful pointers, providing you with a comprehensive understanding of the Third Generation Sequencing market. Here is a more informative breakdown of the key areas covered:

  1. Market Penetration Analysis: Gain a comprehensive understanding of the top players in the Third Generation Sequencing market by exploring their product portfolios in detail. This analysis provides valuable insights into the range of products offered by these industry leaders, enabling you to assess their market presence and competitive advantages.
  2. Product Development and Innovation Insights: Stay abreast of the latest advancements in the Third Generation Sequencing market through detailed insights on upcoming technologies, research and development (R&D) activities, and product launches. This information allows you to identify innovative solutions, assess market trends, and anticipate the direction of the industry.
  3. Competitive Assessment: Delve deep into the strategies employed by the leading players in the Third Generation Sequencing market, evaluating their geographic presence and business segments. This assessment offers a comprehensive understanding of the competitive landscape, enabling you to benchmark your own strategies against industry leaders and identify areas for improvement.
  4. Market Development Analysis: Explore the potential of emerging markets with comprehensive information and analysis. This report analyzes various market segments across different geographies, providing you with valuable insights into the growth opportunities available in specific regions and helping you tailor your expansion strategies accordingly.
  5. Market Diversification Opportunities: Uncover untapped geographies, new product offerings, recent developments, and investments in the Third Generation Sequencing market. This exhaustive information enables you to identify potential areas of diversification, strategically expand your market reach, and seize new opportunities for growth.

By leveraging the insights provided in this report, you will be equipped with a comprehensive understanding of the Third Generation Sequencing market landscape, empowering you to make informed decisions, drive innovation, assess competitors, identify market gaps, and strategically position your business for success.

Table of Contents:

  1. Introduction
  2. Market Segmentation
  3. Executive Summary
  4. Premium Insights
  5. Global Third Generation Sequencing Market: Regulations
  6. Market Overview
  7. Global Third Generation Sequencing Market, By Type
  8. Global Third Generation Sequencing Market, By Application
  9. Global Third Generation Sequencing Market, By Region
  10. Global Third Generation Sequencing Market: Company Landscape
  11. SWOT Analyses
  12. Company Profile
  13. Questionnaires
  14. Related Reports

Download the Complete Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-third-generation-sequencing-market

Explore More Reports:

  • Next Generation Sequencing (NGS) Market, By Product  (Instruments, Consumables and Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research and Others), End User (Pharmaceutical & Biotechnology Companies, Research Centers & Academic and Government Institutes and Hospital & Clinics), Country (U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Switzerland, Russia, Turkey, Belgium, Netherlands and Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific, Brazil and Rest of South America, South Africa and Rest of Middle East And Africa) https://www.databridgemarketresearch.com/reports/global-next-generation-sequencing-ngs-market
  • Next-Generation Sequencing (NGS) Services Market, By Type (Targeted Sequencing/Gene Panels, RNA-Sequencing, De Novo Sequencing, Exome Sequencing, CHiP-Sequencing, Whole-genome Sequencing, Methyl-Sequencing, Other Services), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-time Sequencing, Nanopore Sequencing), Application (Diagnostics, Drug Discovery, Biomarker Discovery, Microbial Genetics, Agriculture, and Animal Research, Other Applications), End User (Academic and Government Institutes and Research Centers, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other End Users) https://www.databridgemarketresearch.com/reports/global-ngs-services-market
  • Clinical Next-Generation Sequencing (NSG) Testing Market, By Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-time Sequencing, Nano Pore Sequencing and Other Sequencing Technologies), Application (Diagnostics, Drug Discovery, Agricultural and Animal Research and Other Applications), End User (Academic Institutes and Research Centres, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies and Other End Users), Service (Human Genome Sequencing, Single Cell Sequencing, Microbial Genome-based Sequencing, Gene Regulation Services, Animal and Plant Sequencing and Other Sequencing Services), Workflow (Pre-Sequencing, Sequencing and Data Analysis), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-clinical-next-generation-sequencing-nsg-testing-market
  • Whole Exome Sequencing Market, By Component (Second-Generation Sequencing and Third-Generation Sequencing), Product and Service (Systems, Kits, and Services), Application (Drug Discovery and Development, Agriculture & Animal Research, Diagnostics, Personalized Medicine, and Others), End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals and Clinics, Clinical Laboratories, and Others), Distribution Channel (Direct Trade, Retail Sales, and Others) https://www.databridgemarketresearch.com/reports/global-whole-exome-sequencing-market
  • Sequencing Driven Metagenomics Market, By Product (Kits and Reagents, Sequencing and Data Analytics Services, Instruments, Consumables, Others), Application (Environmental, Human Health, Agriculture, Biotechnology, Biofuel, Others), End Users (Pharmaceutical Industries, Biotechnology Companies, Research Laboratories, Pathology Laboratories, Academic and Research Institutes, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-sequencing-driven-metagenomics-market
  • Microbiome Sequencing Market, By Sequencing Technology (High-Throughput Sequencing, Sanger Sequencing, SBL, RNA Sequencing, SBS, Third-Generation Sequencing, Whole Genome Sequencing, Targeted Gene Sequencing, Shotgun Sequencing, Others), Component (Reagents & Kits, Instruments), Targeted Disease (CNS Diseases, Gastrointestinal Diseases, Oncology, Infectious Diseases, Others), Application (Personalized Medicine, Genetic Screening, Therapeutic, Drug & Biomarker Discovery, Disease Diagnosis Research, Others), Research Type (Outsourced, In-House), End-User (Pharmaceutical & Biotechnology, Academic Centers & Research Institutes, CROs, Others), Laboratory Type (Dry Lab, Wet Lab), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-microbiome-sequencing-market
  • Sequencing Reagents Market, By Technology (Sanger Sequencing, NGS, Third Generation Sequencing), Type (Library Kits, Template Kits, Control Kits, Sequencing Kits, Others), Application (Oncology, Reproductive Health, Clinical Investigation, Agrigenomics & Forensics, Others), End-User (Academic Research, Clinical Research, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-sequencing-reagents-market
  • Short Read Sequencing Market, By Product (Ins truments, Consumables, Services), Technology (Next- Generation Sequencing, Sanger Sequencing), Workflow (Pre- Sequencing, Sequencing, Data Analysis), Application (Oncology, Clinical Investigation, Reproductive Health, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology and Drug Development, Agrigenomics and Forensics, Consumer Genomics), End- User (Academic Research, Clinical Research, Hospitals and Clinics, Pharma and Biotech Entities, Other), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-short-read-sequencing-market
  • Long Read Sequencing Market, By Technology (Single-Molecule Real- Time Sequencing, Nanopore Sequencing, Synthetic Long Read Sequencing and Others), Product (Instruments, Consumables and Services), Application (Whole Genome Sequencing, Epigenetics, RNA Sequencing, Complex Population, Targeted Sequencing and Others), Workflow (Pre-Sequencing, Sequencing and Data Analysis), End-user (Academic and Research Institutes, Clinical Laboratories, Hospitals, Pharma and Biotech Entities and Others) https://www.databridgemarketresearch.com/reports/global-long-read-sequencing-market

About Data Bridge Market Research:

An absolute way to forecast what the future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adept in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfaction rate.

Contact Us:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com


Primary Logo

You just read:

Third Generation Sequencing Market Set to Witness Unprecedented Growth of USD 28.73 Billion by 2030, Size, Share, Trends, Growth Opportunities and Competitive Outlook

Distribution channels: Consumer Goods, Healthcare & Pharmaceuticals Industry, Science ...


EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire™, tries to define some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines for more information.

We use cookies for analytics, personalized content and ads. By continuing to browse this site, you agree to this use. Learn more